BioSpin Buy Boosts Bruker BioSciences' Shares Nearly 20 Percent

Dec 03, 2007

NEW YORK (GenomeWeb News) - Bruker BioSciences’ shares bolted up 19.5 percent today following this morning’s announcement that it is buying its affiliate Bruker BioSpin for $914 million in cash and stock.

In afternoon trading, Bruker’s shares had risen $1.87 to $11.16.

Bruker BioSpin makes magnetic resonance core technology. It posted $447 million in revenue and $56.6 million in net income in 2006.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

WHO Panel Announced

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

Research Reproducibility Scores

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

Tests for All Diagnosed

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

This Week in Science

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.

Main menu